Spanish AdTech startup Adcities has raised more than €3 million in Seed funding to scale its platform that brings digital precision and real-time analytics to out-of-home (OOH) advertising.
Spanish AdTech startup Adcities has raised more than €3 million in Seed funding to scale its platform that brings digital precision and real-time analytics to out-of-home (OOH) advertising.
Madrid-based Anyformat, a generative-AI platform built to extract, structure and validate information from complex documents, has secured €3.3 million in Seed financing.
Financial automation startup Dost has entered the UK market after closing a £6 million Series A round led by Octopus Ventures, marking the company’s biggest expansion since its founding.
HealthTech scaleup Qida has raised €37 million to accelerate the expansion of its tech-enabled elderly care services across Spain — marking the largest investment ever in Spain’s eldercare sector and one of the biggest funding rounds for a Spanish social impact company.
Emerging biotech Adaptam Therapeutics has raised €3 million in pre-seed funding to advance a new class of cancer immunotherapies that target immunosuppressive myeloid cells, a key driver of resistance in solid tumors.
Growth equity firm Iris Ventures has announced the first close of its second fund, IRIS Fund II, raising €100 million toward a €200 million target to back the next generation of purpose-driven consumer and lifestyle brands across beauty, wellness, nutrition, longevity, and conscious living.
Conversational AI startup Aunoa has secured €1.5 million in funding to expand its intelligent automation platform across Europe and strengthen its presence in high-volume customer engagement sectors.
Anti-fraud startup Acoru has raised €10 million in a Series A round to help banks detect and prevent AI-powered scams, money mule activity, and financial crime before transactions occur.
Drone technology startup Fuvex has raised €1.7 million in the first phase of its Series A round, fueling expansion into new verticals including gas pipelines, agriculture, and security/defense, as well as international markets across Europe and Latin America.
Biotech startup Nanoligent, a leader in targeted nanodrug development for cancer therapy, has secured €12 million in new funding to accelerate its clinical pipeline and manufacturing scale-up.
